Cargando…
Why Calls to Diversify Trial Populations Fall Short
Drawing on a SARS-CoV-2 vaccine trial in a Latinx community in San Diego, we show how trial designs fail to redress structural racism and may introduce new harms. While important, trial diversity alone cannot redress entrenched inequities that affect Black, Indigenous, and People of Color (BIPOC) co...
Autores principales: | Varma, Saiba, Vora, Kalindi, Fox, Keolu, Berkhout, Suze, Benmarhnia, Tarik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759801/ https://www.ncbi.nlm.nih.gov/pubmed/35072131 http://dx.doi.org/10.1016/j.medj.2020.12.012 |
Ejemplares similares
-
Why Do We Need To Diversify the Microbial Sciences?
por: Torres, Alfredo G.
Publicado: (2021) -
Identity, politics, and the pandemic: Why is COVID-19 a disaster for feminism(s)?
por: Berkhout, Suze G., et al.
Publicado: (2020) -
Diversifying Implementation Science: A Global Perspective
por: Bartels, Sophia M., et al.
Publicado: (2022) -
Inferential challenges when assessing racial/ethnic health disparities in environmental research
por: Benmarhnia, Tarik, et al.
Publicado: (2021) -
Why did preterm birth rates fall during the COVID‐19 pandemic?
por: Lisonkova, Sarka, et al.
Publicado: (2022)